Brief: Lixte Biotechnology Got Into Clinical Trial Agreement With Netherlands Cancer Institute

NOMAD Power Solutions

14/06/2024 13:51

June 14 (Reuters) - Lixte Biotechnology Holdings Inc
 LIXT.O :
    * GOT INTO CLINICAL TRIAL AGREEMENT WITH NETHERLANDS CANCER
INSTITUTE
    * AGREEMENT TO CONDUCT A PHASE 1B/2 CLINICAL TRIAL OF
LB-100,
COMBINED WITH ATEZOLIZUMAB FOR PATIENTS WITH METASTATIC COLON
CANCER

Source text for Eikon:  ID:n0001493152-24-023798 
Further company coverage:  LIXT.O 

 ((Reuters.Briefs@thomsonreuters.com;))